EQL Pharma AB (publ) (STO:EQL)
Sweden · Delayed Price · Currency is SEK 91.90
-4.80 (-4.96%)
At close: Aug 1, 2025
EQL Pharma AB Market Cap
EQL Pharma AB has a market cap or net worth of 2.67 billion as of August 1, 2025. Its market cap has increased by 60.66% in one year.
Market Cap
2.67B
Enterprise Value
3.04B
Revenue
373.52M
Ranking
n/a
PE Ratio
63.82
Stock Price
91.90
Market Cap Chart
Since December 17, 2013, EQL Pharma AB's market cap has increased from 78.22M to 2.67B, an increase of 3,314.56%. That is a compound annual growth rate of 35.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 1, 2025 | 2.67B | 13.46% |
| Dec 30, 2024 | 2.35B | 142.51% |
| Dec 29, 2023 | 970.72M | 16.78% |
| Dec 30, 2022 | 831.22M | -26.29% |
| Dec 30, 2021 | 1.13B | -2.27% |
| Dec 30, 2020 | 1.15B | 207.75% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 96.35B |
| Sectra AB | 69.48B |
| Getinge AB | 53.34B |
| Camurus AB | 41.80B |
| Medicover AB | 41.67B |
| Asker Healthcare Group AB | 38.24B |
| Bonesupport Holding AB | 22.39B |
| AddLife AB | 21.08B |